Tag: ES-SCLC

AZ’ Imfinzi bags new approval for lung cancer

by Selina McKee | Sep 1, 2020 | News | 0

The EC has cleared its use for the treatment of extensive-stage small cell lung cancer

NICE u-turn backs Roche’s Tecentriq for small-cell lung cancer

by Selina McKee | May 28, 2020 | News | 0

The drug giant agreed a new price for Tecentriq with NHS England and Improvement

Roche bags small cell lung cancer nod for Tecentriq

by Selina McKee | Mar 20, 2019 | News | 0

Roche’s Tecentriq has won US clearance for use in combination with carboplatin and etoposide (chemotherapy) as first-line treatment for extensive-stage small cell lung cancer (ES-SCLC) in the US, offering patients the first new treatment in more than 20 years.